Valiant Organics reports unaudited Q2 & H1 FY26 financial results
Valiant Organics reported Q2 & H1 FY26 unaudited standalone and consolidated financial results, showing a return to profitability compared to the previous year, despite a sequential quarterly dip.
Financial results are a primary indicator of a company's performance and directly influence investor perception and stock valuation. The significant shift from loss to profit compared to the previous year, alongside a sequential quarterly decline, makes this a high-impact announcement.
The company returned to profitability compared to the significant losses in Q2 FY25, which is positive. However, net profit for Q2 FY26 saw a sequential decline compared to Q1 FY26 for both standalone and consolidated figures, indicating a mixed performance.
* Valiant Organics Limited announced its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2025. * The results were reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on November 13, 2025. * Standalone Financial Highlights for Q2 FY26 (quarter ended September 30, 2025): * Total Income from Operations (Net): ₹15,740.19 lakhs * Net Profit after tax: ₹559.62 lakhs * Basic Earnings Per Share (EPS): ₹2.00 * Consolidated Financial Highlights for Q2 FY26 (quarter ended September 30, 2025): * Total Income from Operations (Net): ₹15,750.21 lakhs * Net Profit after tax: ₹566.19 lakhs * Basic Earnings Per Share (EPS): ₹2.02 * Half-Year Ended September 30, 2025 (H1 FY26): * Standalone Net Profit after tax: ₹1,317.47 lakhs * Consolidated Net Profit after tax: ₹1,386.47 lakhs * The company showed significant improvement from losses reported in the corresponding quarter and half-year of the previous fiscal year.
What to do with a filing like this
Valiant Organics Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Valiant Organics Limited. Read the original for the full detail.